About Us


PCORI Emerging Health Care Innovation Brief -- With a background showing a human genome helix

The latest Emerging Health Care Innovation Brief highlights some of the advances that researchers globally are making toward more effective treatment approaches for patients with cancer.

The Topics to Watch spotlight a second-generation tyrosine kinase inhibitor to treat early-stage non–small cell lung cancer, as well as oncolytic viruses, a form of biologic therapy to selectively infect and destroy cancer cells.

View the Innovation Brief

This PCORI Emerging Health Care Innovation Brief is part of a series highlighting important topics of interest identified during the ongoing scanning and topic identification process or through a stakeholder survey process.

Useful Links

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Subscribe to PCORI Emails


Hand pointing to email icon